179 related articles for article (PubMed ID: 36453607)
1. A multi-scale, multi-region and attention mechanism-based deep learning framework for prediction of grading in hepatocellular carcinoma.
Wei J; Ji Q; Gao Y; Yang X; Guo D; Gu D; Yuan C; Tian J; Ding D
Med Phys; 2023 Apr; 50(4):2290-2302. PubMed ID: 36453607
[TBL] [Abstract][Full Text] [Related]
2. Influence of different region of interest sizes on CT-based radiomics model for microvascular invasion prediction in hepatocellular carcinoma.
Zhao H; Feng Z; Li H; Yao S; Zheng W; Rong P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1049-1057. PubMed ID: 36097772
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
4. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma.
Yang Y; Zhou Y; Zhou C; Ma X
Eur J Surg Oncol; 2022 May; 48(5):1068-1077. PubMed ID: 34862094
[TBL] [Abstract][Full Text] [Related]
5. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
Ma X; Wei J; Gu D; Zhu Y; Feng B; Liang M; Wang S; Zhao X; Tian J
Eur Radiol; 2019 Jul; 29(7):3595-3605. PubMed ID: 30770969
[TBL] [Abstract][Full Text] [Related]
6. [Prediction of microvascular invasion in hepatocellular carcinoma based on multi-phase dynamic enhanced CT radiomics feature and multi-classifier hierarchical fusion model].
Zhong W; Liang F; Yang R; Zhen X
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):260-269. PubMed ID: 38501411
[TBL] [Abstract][Full Text] [Related]
7. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
[TBL] [Abstract][Full Text] [Related]
8. Radiomics analysis of ultrasound to predict recurrence of hepatocellular carcinoma after microwave ablation.
Wu JP; Ding WZ; Wang YL; Liu S; Zhang XQ; Yang Q; Cai WJ; Yu XL; Liu FY; Kong D; Zhong H; Yu J; Liang P
Int J Hyperthermia; 2022; 39(1):595-604. PubMed ID: 35435082
[TBL] [Abstract][Full Text] [Related]
9. [Value of the application of enhanced CT radiomics and machine learning in preoperative prediction of microvascular invasion in hepatocellular carcinoma].
Yu YX; Hu CH; Wang XM; Fan YF; Hu MJ; Shi C; Hu S; Zhu M; Zhang Y
Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1239-1245. PubMed ID: 34865392
[No Abstract] [Full Text] [Related]
10. DLNLF-net: Denoised local and non-local deep features fusion network for malignancy characterization of hepatocellular carcinoma.
Huang H; Xie Y; Wang G; Zhang L; Zhou W
Comput Methods Programs Biomed; 2022 Dec; 227():107201. PubMed ID: 36335751
[TBL] [Abstract][Full Text] [Related]
11. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
12. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma.
Che F; Xu Q; Li Q; Huang ZX; Yang CW; Wang LY; Wei Y; Shi YJ; Song B
World J Gastroenterol; 2022 Apr; 28(14):1479-1493. PubMed ID: 35582676
[TBL] [Abstract][Full Text] [Related]
13. Grading of hepatocellular carcinoma based on diffusion weighted images with multiple b-values using convolutional neural networks.
Zhou W; Wang G; Xie G; Zhang L
Med Phys; 2019 Sep; 46(9):3951-3960. PubMed ID: 31169907
[TBL] [Abstract][Full Text] [Related]
14. Improving radiomics reproducibility using deep learning-based image conversion of CT reconstruction algorithms in hepatocellular carcinoma patients.
Lee H; Chang W; Kim HY; Sung P; Cho J; Lee YJ; Kim YH
Eur Radiol; 2024 Mar; 34(3):2036-2047. PubMed ID: 37656175
[TBL] [Abstract][Full Text] [Related]
15. Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma.
Dong X; Yang J; Zhang B; Li Y; Wang G; Chen J; Wei Y; Zhang H; Chen Q; Jin S; Wang L; He H; Gan M; Ji W
J Magn Reson Imaging; 2024 Jan; 59(1):108-119. PubMed ID: 37078470
[TBL] [Abstract][Full Text] [Related]
16. Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.
Song D; Wang Y; Wang W; Wang Y; Cai J; Zhu K; Lv M; Gao Q; Zhou J; Fan J; Rao S; Wang M; Wang X
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3757-3767. PubMed ID: 33839938
[TBL] [Abstract][Full Text] [Related]
17. Effect of multiple peritumoral regions of interest ranges based on computed tomography radiomics for the prediction of early recurrence of hepatocellular carcinoma after resection.
Kang W; Cao X; Luo J
Quant Imaging Med Surg; 2023 Oct; 13(10):6668-6682. PubMed ID: 37869280
[TBL] [Abstract][Full Text] [Related]
18. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
[TBL] [Abstract][Full Text] [Related]
19. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
[TBL] [Abstract][Full Text] [Related]
20. Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals.
Liu SC; Lai J; Huang JY; Cho CF; Lee PH; Lu MH; Yeh CC; Yu J; Lin WC
Cancer Imaging; 2021 Oct; 21(1):56. PubMed ID: 34627393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
